SBIR-STTR Award

Multiplex Mass Spectrometric Immunoassays
Award last edited on: 11/22/19

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$1,130,272
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Dobrin Nedelkov

Company Information

Intrinsic Bioprobes Inc (AKA: IBI)

2155 East Conference Drive Suite 104
Tempe, AZ 85284
   (480) 804-1778
   N/A
   www.intrinsicbio.com
Location: Single
Congr. District: 09
County: Maricopa

Phase I

Contract Number: 261200800055C-0-0-1
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2008
Phase I Amount
$147,160
The objective of the Phase II research project is to continue the development of a quantitative, automated, high throughput, multiplex affinity protein capture technology platform and multiplex mass spectrometric immunoassays for the analysis of more than 50 cancer-related peptides and proteins from bodily fluids. The projects final goal is the assembly of kits containing the multiplex assays, reagents and protocols and the evaluation and optimization of variables affecting product quality, such as packaging and storage conditions.

Phase II

Contract Number: 261200800055C-1-0-1
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2009
Phase II Amount
$983,112
The objective of the Phase II research project is to continue the development of a quantitative, automated, high throughput, Multiplex affinity protein capture technology platform and Multiplex Mass Spectrometric Immunoassays for the analysis of more than 50 cancer-related peptides and proteins from bodily fluids. The projects final goal is the assembly of kits containing the Multiplex assays, reagents and protocols and the evaluation and optimization of variables affecting product quality, such as packaging and storage conditions.

NIH Spending Category:
Biotechnology; Cancer

Project Terms:
No Project Terms available.